Actively Recruiting

Phase Not Applicable
Age: 20Years - 45Years
FEMALE
NCT06566274

Thumbtack Needle in the Treatment of NVP

Led by Dongmei Huang · Updated on 2026-01-08

320

Participants Needed

13

Research Sites

221 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This project intends to use multi-center, large-sample, randomized, controlled, blinded clinical trials to observe the clinical efficacy and safety of thumbtack needle (TN) on nausea and vomiting in pregnancy (NVP).

CONDITIONS

Official Title

Thumbtack Needle in the Treatment of NVP

Who Can Participate

Age: 20Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 20 to 45 years
  • Gestational age between 6 and 12 weeks with ultrasound-confirmed intrauterine single or multiple pregnancy
  • Weight loss less than 10% compared to before pregnancy
  • Diagnosed with moderate to severe nausea and vomiting in pregnancy (PUQE score 6 to 15)
  • Voluntary signing of informed consent
Not Eligible

You will not qualify if you...

  • Age outside 20 to 45 years range
  • Gestational age less than 6 weeks or more than 12 weeks
  • PUQE score less than 6
  • Frequent nausea and vomiting with weight loss over 10% or symptoms such as listlessness, paleness, dry skin, sunken eyes, or very low urine output
  • Body temperature over 38 0C, blood pressure outside normal ranges, heart rate 100 beats per minute or higher, or oxygen saturation below 95%
  • Urinalysis showing high urine ketones or protein levels
  • Blood tests showing low potassium or sodium, abnormal liver function, or kidney dysfunction
  • Presence of digestive diseases causing nausea and vomiting like infections, ulcers, cholecystitis, pancreatitis, viral hepatitis, or digestive tract tumors
  • Immune diseases such as lupus, scleroderma, dermatomyositis, IgG4-related diseases, or immune nephropathy
  • Uncorrected endocrine diseases like diabetes, Addison's disease, thyroid tumors, or adrenal tumors
  • Neurological diseases such as migraine, neuromyelitis optica, epilepsy, or neurological tumors
  • Use of monoamine oxidase inhibitors
  • Use of antiemetic drugs within the past week
  • Previous thumbtack needle treatment within the past 3 months
  • Unwillingness to sign informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 13 locations

1

Jingzhou Hospital of Traditional Chinese Medicine

Jingzhou, Hubei, China, 434300

Actively Recruiting

2

Nanzhang County Traditional Chinese Medicine Hospital

Nanzhang Chengguanzhen, Hubei, China, 441500

Actively Recruiting

3

Qianjiang Central Hospital

Qianjiang, Hubei, China, 433100

Actively Recruiting

4

Qianjiang Maternal and Child Health Care Hospital

Qianjiang, Hubei, China, 433199

Actively Recruiting

5

Shiyan People's Hospital

Shiyan, Hubei, China, 442099

Actively Recruiting

6

Suizhou Maternal and Child Health Care Hospital

Suizhou, Hubei, China, 441399

Actively Recruiting

7

Wuhan Jinxin Gynecology and Obstetrics Hospital of Integrative Medicine

Wuhan, Hubei, China, 430014

Actively Recruiting

8

Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430030

Actively Recruiting

9

Xiangyang Hospital of Traditional Chinese Medicine

Xiangyang, Hubei, China, 441001

Actively Recruiting

10

Xiangyang Central Hospital

Xiangyang, Hubei, China, 441106

Actively Recruiting

11

Xiaogan Maternal and Child Health Care Hospital

Xiaogan, Hubei, China, 432001

Actively Recruiting

12

Dongchangfu District Maternal and Child Health Care Hospital of Liaocheng City

Liaocheng, Shandong, China, 252004

Actively Recruiting

13

Aksu Prefecture Maternal and Child Health Hospital

Aksu, Xinjiang, China, 843099

Actively Recruiting

Loading map...

Research Team

D

Dongmei Huang, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here